Exchange: OTC·Updated 08:05 AM EDT

ORPOF OSE Immunotherapeutics

$4.43
$0.6929
(15.64%)
Pre-Market
Prev Close $4.43
EarningsSep 28
Mkt Cap$104.19M
Vol4,200.00

About ORPOF

OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on developing and partnering therapies to control the immune system for immuno-oncology and immuno-inflammation. The company was founded by Dominique Constantini on November 17, 2004 and is headquartered in Nantes, France.
50

Neutral Sentiment

How do you feel about ORPOF?

Advertisement|Remove ads.